Biopharma Plasma: a key player in reforming the blood system in Ukraine

Oksana Mulyarchuk is the CEO of Biopharma plasma, a Ukrainian biotechnology company specializing in the development and manufacture of drugs based on human donor plasma. Over the years, Oksana has increased the number of plasma centers in Ukraine from 3 to 16, and opened the first center in Romania. Together with her team, she is actively reforming the state blood system. Oksana is currently studying at kmbs under the Executive MBA-42 program. “The school gave me the opportunity to get out of my professional bubble, look at the client differently and learn from the experience of my colleagues.” Oksana shared with kmbs the story of how Biopharma plasma operates in the face of a full-scale invasion, the challenges it faces every day, the importance of the team, and the reasons that prompted her to choose a long-term study program.